BEECOX MR tablets 10s

Beecox MR is a triple-combination tablet combining three distinct analgesic and anti-inflammatory agents to provide comprehensive pain relief for musculoskeletal conditions:

Celecoxib 200 mg is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces prostaglandin synthesis responsible for pain, inflammation, and fever, while sparing COX-1 (gastric-protective), thereby reducing the risk of GI ulceration compared to non-selective NSAIDs.

Paracetamol 325 mg provides additive central and peripheral analgesic and antipyretic effects, complementing the anti-inflammatory action of celecoxib.

Chlorzoxazone 250 mg is a centrally acting skeletal muscle relaxant that acts on the spinal cord and brain stem to reduce muscle spasm, which is a significant contributor to back pain and musculoskeletal pain syndromes.

Together, this combination targets three pain pathways simultaneously: inflammation (celecoxib), nociception (paracetamol), and muscle spasm (chlorzoxazone), making Beecox MR particularly suited to acute musculoskeletal pain with a spasm component.

Approved Indications

•       Acute low back pain with muscle spasm

•       Cervicalgia (neck pain) with muscle stiffness

•       Musculoskeletal pain syndromes (myalgia, fibromyalgia)

•       Post-traumatic pain with inflammation and spasm

•       Acute painful shoulder and limb conditions

•       Osteoarthritis pain (short-term management)

•       Rheumatoid arthritis pain (adjunct to disease-modifying therapy)

General Instructions

Take with food or milk to reduce the risk of stomach irritation from celecoxib. Swallow tablets whole with a full glass of water. Avoid taking with alcohol.

Dosage, Adults

One tablet twice daily (every 12 hours) with food. Do not exceed 2 tablets per day. Use the lowest effective dose for the shortest duration necessary.

Elderly Patients

Initiate with caution. Elderly patients are at higher risk of NSAID-associated cardiovascular, GI, and renal adverse effects. Start at the lower end; monitor closely.

Missed Dose

Take the missed dose as soon as remembered. Skip if next dose is within 6 hours. Do not double up.

Duration of Treatment

Beecox MR is intended for short-term use (7–14 days) for acute musculoskeletal pain. Long-term use requires specialist supervision due to celecoxib's cardiovascular risk.

Common Side Effects

•       Dyspepsia, heartburn, and nausea (celecoxib, less than with non-selective NSAIDs)

•       Dizziness and lightheadedness (chlorzoxazone effect)

•       Drowsiness and sedation (chlorzoxazone, do not drive)

•       Headache

•       Peripheral oedema (fluid retention from celecoxib)

Less Common Side Effects

•       Elevated liver enzymes (chlorzoxazone and celecoxib)

•       Diarrhoea or constipation

•       Rash or skin reactions

•       Insomnia

•       Hypertension (celecoxib, blood pressure elevation possible)

Serious / Seek Immediate Medical Attention

•       Cardiovascular events (MI, stroke), risk increases with prolonged use and in high-CV-risk patients (celecoxib)

•       Serious GI events: peptic ulceration and GI bleeding, though lower risk than non-selective NSAIDs

•       Severe hepatotoxicity (chlorzoxazone), rare but documented; yellow discolouration of skin/eyes, dark urine

•       Serious skin reactions: Stevens-Johnson syndrome, TEN (very rare)

•       Acute kidney injury (celecoxib + paracetamol in overdose)

•       Anaphylaxis (particularly in patients with sulfonamide or NSAID hypersensitivity)

•       Despite selective COX-2 inhibition, celecoxib still carries cardiovascular risk, use the lowest effective dose for the shortest duration, particularly in patients with hypertension, diabetes, or established cardiovascular disease.

•       Celecoxib contains a sulfonamide moiety, use with caution in patients with sulfonamide hypersensitivity.

•       Chlorzoxazone causes significant sedation, patients should not drive, operate machinery, or consume alcohol during treatment.

•       Serious hepatotoxicity with chlorzoxazone has been reported (hepatocellular necrosis), discontinue immediately if jaundice or abnormal liver tests occur.

•       Monitor blood pressure in hypertensive patients, NSAIDs (including COX-2 inhibitors) can elevate BP and antagonise antihypertensive therapy.

•       Avoid additional paracetamol-containing products during treatment, risk of unintentional paracetamol overdose and hepatotoxicity.

•       Do not use in pregnancy during the third trimester, celecoxib may cause premature ductus arteriosus closure and impair fetal renal function.

•       In Kenyan patients on aspirin for cardiovascular protection, celecoxib does not substitute for low-dose aspirin, continue aspirin if prescribed.

Always inform your pharmacist and prescriber about all medicines, supplements, and herbal remedies you are currently taking.

Warfarin / anticoagulants: COX-2 inhibitors may enhance anticoagulant effect, increased bleeding risk; monitor INR

ACE inhibitors / ARBs / diuretics: Reduced antihypertensive and diuretic effect; increased risk of acute kidney injury

Lithium: COX-2 inhibitors reduce lithium renal clearance, increased lithium toxicity risk

Fluconazole: Significantly increases celecoxib plasma levels via CYP2C9 inhibition, may require celecoxib dose reduction

Rifampicin: Induces CYP2C9, reduces celecoxib levels

Alcohol: Combined with paracetamol and chlorzoxazone, increased hepatotoxicity and sedation risk

CNS depressants (benzodiazepines, opioids, antihistamines): Additive CNS depression and sedation with chlorzoxazone

Other NSAIDs / aspirin (> 325 mg): Increased GI toxicity risk, avoid concurrent use

Other paracetamol-containing products: Risk of paracetamol overdose and acute liver failure, check all concurrent medications

Store below 25°C in a cool, dry place away from direct sunlight and moisture. Keep in the original packaging. Keep out of reach of children. Do not use after the expiry date.

Beecox MR is a Prescription Only Medicine (POM) in Kenya due to the celecoxib and chlorzoxazone components. Prescription assessment should include cardiovascular risk, renal function, and concurrent medications. Pharmily requires a valid prescription for dispensing.

Beecox MR exemplifies the fixed-dose combination analgesic trend in the Kenyan private pharmacy market. Its three-component design offers practical multi-modal pain relief for musculoskeletal conditions but requires careful patient selection and counselling due to the distinct risk profiles of each component.

The most critical dispensing check is unintentional paracetamol stacking. The 325 mg paracetamol per tablet means a patient taking two tablets daily receives 650 mg/day from Beecox alone, well within the safe range, but if they are also taking paracetamol-containing combination cold remedies, cocodamol, or other combination analgesics, toxicity risk rises. Counsel explicitly and check the full medication list.

Chlorzoxazone's sedative potential mandates clear driving and machinery warnings at every dispensing. In Kenyan working adults, this side effect is a significant compliance and occupational safety issue. The risk of chlorzoxazone-induced hepatotoxicity, while rare, is important to document, advise patients to report any yellowness of the eyes immediately.

For patients on celecoxib long-term (osteoarthritis), periodic assessment of cardiovascular risk, blood pressure, and renal function is essential.

Can I take Beecox MR with paracetamol tablets or Panadol?

A: No. Beecox MR already contains 325 mg of paracetamol per tablet. Taking additional paracetamol products alongside it can lead to a dangerous overdose, acute liver failure can occur with too much paracetamol. Check all your medicines with your pharmacist.

Why does Beecox MR make me feel drowsy?

A: Chlorzoxazone, the muscle relaxant in Beecox MR, acts on the central nervous system and commonly causes drowsiness. Do not drive, operate heavy machinery, or drink alcohol while taking this medicine.

Is Beecox MR safe if I have a heart condition?

A: Not without medical guidance. The celecoxib component carries cardiovascular risk (risk of heart attack or stroke), especially with prolonged use or in patients with existing heart disease or high blood pressure. Discuss with your cardiologist or doctor before use.

How long can I take Beecox MR for?

A: Beecox MR is recommended for short-term use only, typically 7 to 14 days for acute pain. Prolonged use of celecoxib and chlorzoxazone carries increasing risks. If your pain is ongoing, see your doctor to discuss long-term management options.